Amyloid-beta clearance in Alzheimer's disease
Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer's disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogene...
Kaydedildi:
Yazar: | Robert Marr (auth) |
---|---|
Diğer Yazarlar: | Eliezer Masliah (auth) |
Materyal Türü: | Elektronik Kitap Bölümü |
Dil: | İngilizce |
Baskı/Yayın Bilgisi: |
Frontiers Media SA
2015
|
Seri Bilgileri: | Frontiers Research Topics
|
Konular: | |
Online Erişim: | DOAB: download the publication DOAB: description of the publication |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Benzer Materyaller
-
An Infectious Origin of Alzheimer's Disease: An End for This Devastating Disorder?
Baskı/Yayın Bilgisi: (2020) -
The Alzheimer's Disease Challenge
Baskı/Yayın Bilgisi: (2019) -
The Physiological Functions of the Amyloid Precursor Protein Gene Family
Yazar:: Ulrike C. Muller
Baskı/Yayın Bilgisi: (2017) -
Amyloid-β Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases
Baskı/Yayın Bilgisi: (2023) -
Amyloid-β
Baskı/Yayın Bilgisi: (2023)